Literature DB >> 28314686

Epigenetics: a new tool for meningioma management?

Marc Sanson1, Michel Kalamarides2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28314686     DOI： 10.1016/S1470-2045(17)30153-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas.

Authors:  Yu Sakai; Satoru Miyawaki; Yu Teranishi; Atsushi Okano; Kenta Ohara; Hiroki Hongo; Daiichiro Ishigami; Daisuke Shimada; Jun Mitsui; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

2.  Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.

Authors:  Yu Teranishi; Atsushi Okano; Satoru Miyawaki; Kenta Ohara; Daiichiro Ishigami; Hiroki Hongo; Shogo Dofuku; Hirokazu Takami; Jun Mitsui; Masako Ikemura; Daisuke Komura; Hiroto Katoh; Tetsuo Ushiku; Shumpei Ishikawa; Masahiro Shin; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Acta Neuropathol Commun       Date:  2022-05-15       Impact factor: 7.578

3.  Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors.

Authors:  Alena Kopkova; Jiri Sana; Tana Machackova; Marek Vecera; Lenka Radova; Karolina Trachtova; Vaclav Vybihal; Martin Smrcka; Tomas Kazda; Ondrej Slaby; Pavel Fadrus
Journal:  Cancers (Basel)       Date:  2019-10-12       Impact factor: 6.639

Review 4.  Bone Invasive Meningioma: Recent Advances and Therapeutic Perspectives.

Authors:  Hajime Takase; Tetsuya Yamamoto
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

Review 5.  Recent advances in managing/understanding meningioma.

Authors:  Nawal Shaikh; Karan Dixit; Jeffrey Raizer
Journal:  F1000Res       Date:  2018-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.